1. Medtech Insight
  2. >>Device Area
  3. >>Combination Products

EMA’s Advanced Therapies Panel To Set Up Medtech Group

 
• By Vibha Sharma

The 2020 work plan of the European Medicines Agency’s Committee on Advanced Therapies includes initiatives to support the implementation of the EU regulations on medical devices and IVDs. 

EMA_Amsterdam
EMA’s CAT Has A Busy Work Plan For 2020 • Source: Shutterstock

The European Medicines Agency’s Committee on Advanced Therapies has a busy work schedule for this year that includes plans to establish an informal group to help with the implementation of the EU regulations on medical devices and IVDs. Also, there are plans to finalize at least two key guidelines on advanced therapy medicinal products (ATMPs).

As per the CAT’s 2020 work plan, there are plans to set up an informal medical device focus group...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Combination Products

More from Device Area

Daye Breaks Into Hormone Self-Testing, Adds New Data To Extensive Gynecology Database

 
• By Natasha Barrow

Daye is launching an at-home reproductive hormone testing service in the UK, utilizing a painless upper arm blood collection method. The product’s UKAS lab accreditation helps build credibility with healthcare providers.

Zimmer Biomet Targets 2027 Launch For Semi-Autonomous Orthopedic Robot After Monogram Acquisition

 
• By Shubham Singh

Zimmer Biomet expects the Monogram deal to meet its financial and strategic criteria, be neutral to adjusted earnings per share from 2025 through 2027 and become accretive thereafter.

Injuries And Deaths Linked To Boston Scientific Cardiac Devices. Company Responds

 
• By Brian Bossetta

The US FDA issued a pair of early alerts on Wednesday warning customers about serious adverse events associated with two Boston Scientific cardiac devices. Both alerts include numerous reports of injuries and deaths and are part of the FDA’s ongoing pilot to enhance its recall process.